115 related articles for article (PubMed ID: 7438537)
21. Localization of preformed, circulating immune complexes in murine skin.
Joselow SA; Mannik M
J Invest Dermatol; 1984 Apr; 82(4):335-40. PubMed ID: 6368700
[TBL] [Abstract][Full Text] [Related]
22. Studies of mononuclear phagocyte function in the rat. I. Saturation and recovery following intravenous administration of soluble human serum albumin (HSA)--anti-HSA complexes.
Bourne JT; Raynor WJ; Verrier Jones J
Clin Exp Immunol; 1983 Jan; 51(1):69-76. PubMed ID: 6831772
[TBL] [Abstract][Full Text] [Related]
23. Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice.
Hogben DN; Devey ME
Clin Exp Immunol; 1986 Dec; 66(3):648-53. PubMed ID: 3568452
[TBL] [Abstract][Full Text] [Related]
24. Metabolism and clearance of antibody-excess immune complexes in lactating mice.
Kim YW; Halsey JF
J Immunol; 1982 Aug; 129(2):619-22. PubMed ID: 7086141
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
26. Alterations in plasma clearance and tissue localization of model immune complexes in rats with streptozotocin-induced diabetes.
Abrass CK; Hori MT
Immunology; 1987 Mar; 60(3):331-6. PubMed ID: 2437017
[TBL] [Abstract][Full Text] [Related]
27. Clearance of immune complexes formed in normal and leukaemic rats.
Shepherd PS; Pendry RA; Dean CJ
Br J Cancer; 1980 Apr; 41(4):562-6. PubMed ID: 7387854
[TBL] [Abstract][Full Text] [Related]
28. Factors that modulate clearance and ultimate fate of a specific schistosome antigen (GASP) in schistosome infections.
Nash TE
J Immunol; 1982 Apr; 128(4):1608-13. PubMed ID: 6174609
[TBL] [Abstract][Full Text] [Related]
29. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes.
Kurlander RJ; Ellison DM; Hall J
J Immunol; 1984 Aug; 133(2):855-62. PubMed ID: 6736648
[TBL] [Abstract][Full Text] [Related]
30. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.
Skogh T; Stendahl O
Immunology; 1983 May; 49(1):53-9. PubMed ID: 6404812
[TBL] [Abstract][Full Text] [Related]
31. Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake.
Takahashi N; Fujita T; Takata Y; Tamura N
Clin Exp Immunol; 1985 Jul; 61(1):176-82. PubMed ID: 3899427
[TBL] [Abstract][Full Text] [Related]
32. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.
Adam C; Thoua Y; Ronco P; Verroust P; Tovey M; Morel-Maroger L
Clin Exp Immunol; 1980 May; 40(2):373-82. PubMed ID: 6160000
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of exogenous single stranded DNA in normal and NZB/W mice.
Chia D; Dorsch C; Barnett EV; Levy L
Immunology; 1977 Mar; 32(3):351-8. PubMed ID: 849880
[TBL] [Abstract][Full Text] [Related]
34. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
35. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
Okudaira H; Terada E; Okudaira K
Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
[TBL] [Abstract][Full Text] [Related]
36. Studies on NEM-treated erythrocyte clearance in the rabbit, with special reference to the effects of circulating immune complexes.
Lawrence S; Lockwood CM; Peters DK
Clin Exp Immunol; 1981 May; 44(2):433-9. PubMed ID: 7307342
[TBL] [Abstract][Full Text] [Related]
37. An abnormality of immune complex kinetics in murine lupus.
Magilavy DB; Rifai A; Plotz PH
J Immunol; 1981 Feb; 126(2):770-4. PubMed ID: 6161189
[TBL] [Abstract][Full Text] [Related]
38. Complement-mediated defect in clearance and sequestration of sensitized, autologous erythrocytes in rodent malaria.
Pappas MG; Nussenzweig RS; Nussenzweig V; Shear HL
J Clin Invest; 1981 Jan; 67(1):183-92. PubMed ID: 7005263
[TBL] [Abstract][Full Text] [Related]
39. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
40. p30-Anti-p30 immune complexes: intravascular clearance and extravascular sequestration in rats bearing Moloney sarcoma.
Jennette JC; Feldman JD
J Immunol; 1978 Nov; 121(5):1696-700. PubMed ID: 712062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
